Go Pro
→ Iran War Shock: What I Was Told In That Private Meeting (From Banyan Hill Publishing) (Ad)tc pixel Free CHCT Stock Alerts

Community Healthcare Trust (CHCT) Financials

Community Healthcare Trust logo
$17.91 -0.10 (-0.56%)
Closing price 07/8/2026 03:59 PM Eastern
Extended Trading
$17.89 -0.02 (-0.14%)
As of 07/8/2026 05:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Community Healthcare Trust

Annual Income Statements for Community Healthcare Trust

This table shows Community Healthcare Trust's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -1.46 2.72 3.51 4.40 8.38 19 22 22 7.71 -3.18 5.10
Consolidated Net Income / (Loss)		 -1.46 2.72 3.51 4.40 8.38 19 22 22 7.71 -3.18 5.10
Net Income / (Loss) Continuing Operations		 -1.09 -1.84 3.51 4.40 8.38 19 23 22 7.71 -3.18 5.10
Total Pre-Tax Income 		-1.09 -1.84 3.03 2.86 9.81 28 23 22 8.02 -3.18 5.13
Total Revenue		 8.67 19 37 43 52 76 80 86 114 116 133
Net Interest Income / (Expense)		 0.04 -1.18 1.09 -5.88 -8.86 0.17 -10 -12 0.81 0.53 0.03
Total Interest Income		 0.04 0.00 1.09 0.42 0.44 0.17 0.06 0.07 0.81 0.53 0.03
Investment Securities Interest Income		 0.04 - 1.02 0.42 - 0.17 0.06 - 0.81 0.53 0.03
Total Interest Expense		 0.00 1.18 0.00 6.30 9.30 0.00 11 12 0.00 0.00 0.00
Total Non-Interest Income		 8.63 21 36 49 61 76 91 98 113 116 133
Other Service Charges		 0.00 - 0.18 2.10 2.58 1.76 2.92 3.58 4.16 1.22 -0.16
Net Realized & Unrealized Capital Gains on Investments		 - 0.00 - - - - - - -0.10 -0.12 12
Other Non-Interest Income		 8.63 21 36 46 58 74 88 94 109 115 121
Provision for Credit Losses		 - - - - - - - 0.00 0.00 11 8.67
Total Non-Interest Expense		 9.76 21 30 40 42 48 58 64 88 85 92
Property & Liability Insurance Claims		 2.01 4.74 8.68 9.94 12 14 15 17 21 23 24
Other Operating Expenses		 2.54 3.38 3.95 5.63 7.72 8.77 12 15 27 19 25
Depreciation Expense		 5.20 13 18 20 22 25 30 32 40 43 44
Nonoperating Income / (Expense), net		 - 0.03 -3.95 0.30 - - 0.24 - -18 -24 -27
Income Tax Expense		 - 0.00 -0.48 - 1.43 0.08 - 0.04 0.31 0.00 0.02
Basic Earnings per Share		 ($0.31) $0.24 $0.19 $0.19 $0.37 $0.80 $0.87 $0.81 $0.20 ($0.23) $0.08
Weighted Average Basic Shares Outstanding		 4.73M 11.24M 14.82M 17.67M 18.69M 21.58M 23.26M 23.63M 25.20M 26.53M 26.86M
Diluted Earnings per Share		 ($0.31) $0.24 $0.19 $0.19 $0.37 $0.80 $0.87 $0.81 $0.20 ($0.23) $0.08
Weighted Average Diluted Shares Outstanding		 4.73M 11.32M 14.82M 17.67M 18.69M 21.58M 23.26M 23.63M 25.20M 26.53M 26.86M
Weighted Average Basic & Diluted Shares Outstanding		 4.70M 11.30M 18.50M 18.72M 21.63M 24.01M 25.07M 26.02M 27.68M 28.34M 28.57M
Cash Dividends to Common per Share		 $0.52 $1.53 $1.57 $1.61 $1.65 $1.69 $1.73 $1.77 $1.81 $1.85 $1.89

Quarterly Income Statements for Community Healthcare Trust

This table shows Community Healthcare Trust's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 3.49 4.57 3.67 -10 1.75 1.83 1.59 -13 1.64 14 2.55
Consolidated Net Income / (Loss)		 3.49 4.57 3.67 -10 1.75 1.83 1.59 -13 1.64 14 2.55
Net Income / (Loss) Continuing Operations		 3.49 4.57 3.67 -10 1.75 1.83 1.59 -13 1.64 14 2.55
Total Pre-Tax Income 		3.82 4.47 3.67 -10 1.75 1.84 1.59 -13 1.64 14 2.55
Total Revenue		 24 24 24 28 30 11 24 29 30 44 31
Net Interest Income / (Expense)		 -4.64 -4.98 -5.06 0.31 0.21 -19 -6.35 0.01 0.01 0.02 0.00
Total Interest Income		 0.00 0.04 0.00 0.31 0.21 0.02 0.00 0.01 0.01 0.02 0.00
Investment Securities Interest Income		 - - - 0.31 0.21 - 0.00 0.01 0.01 0.02 0.00
Total Interest Expense		 4.64 5.02 5.06 0.00 0.00 19 6.35 0.00 0.00 - 0.00
Total Non-Interest Income		 29 29 29 28 30 29 30 29 30 44 31
Other Service Charges		 1.05 1.02 0.99 -0.39 0.30 0.32 0.35 -1.04 0.27 0.27 0.26
Net Realized & Unrealized Capital Gains on Investments		 - - - - 0.01 - - - -0.89 - -0.05
Other Non-Interest Income		 28 28 28 28 29 29 30 30 31 31 31
Total Non-Interest Expense		 20 20 21 21 22 21 22 27 21 22 22
Property & Liability Insurance Claims		 5.46 5.60 5.79 5.57 5.99 5.49 6.10 5.59 5.93 6.01 6.37
Other Operating Expenses		 3.62 3.73 4.55 4.76 4.94 4.81 5.10 11 4.66 4.78 5.11
Depreciation Expense		 11 10 10 11 11 11 11 11 11 11 11
Nonoperating Income / (Expense), net		 - - - -6.13 -6.25 - 0.00 -5.95 -7.08 -7.60 -6.80
Basic Earnings per Share		 $0.11 $0.17 $0.11 ($0.42) $0.04 $0.04 $0.03 ($0.50) $0.03 $0.52 $0.07
Weighted Average Basic Shares Outstanding		 25.51M 25.20M 26.30M 26.48M 26.66M 26.53M 26.73M 26.80M 26.93M 26.86M 26.99M
Diluted Earnings per Share		 $0.11 $0.17 $0.11 ($0.42) $0.04 $0.04 $0.03 ($0.50) $0.03 $0.52 $0.07
Weighted Average Diluted Shares Outstanding		 25.51M 25.20M 26.30M 26.48M 26.66M 26.53M 26.73M 26.80M 26.93M 26.86M 26.99M
Weighted Average Basic & Diluted Shares Outstanding		 27.26M 27.68M 27.70M 28.06M 28.24M 28.34M 28.34M 28.37M 28.47M 28.57M 28.57M
Cash Dividends to Common per Share		 $0.45 - $0.46 $0.46 $0.46 - $0.47 $0.47 $0.47 - $0.48

Annual Cash Flow Statements for Community Healthcare Trust

This table details how cash moves in and out of Community Healthcare Trust's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 2.02 -0.45 0.56 0.26 -0.37 0.87 -0.03 9.20 -7.44 -0.25 -1.04
Net Cash From Operating Activities		 2.97 15 22 24 32 48 56 60 61 59 56
Net Cash From Continuing Operating Activities		 4.46 15 22 24 32 48 56 60 61 59 56
Net Income / (Loss) Continuing Operations		 0.00 2.72 3.51 4.40 8.38 19 22 22 7.71 -3.18 5.10
Consolidated Net Income / (Loss)		 - 2.72 3.51 4.40 8.38 19 22 22 7.71 -3.18 5.10
Provision For Loan Losses		 0.07 0.16 - - - - - 0.00 0.00 11 8.67
Depreciation Expense		 5.32 13 18 20 22 25 30 32 40 43 44
Amortization Expense		 - - - 0.63 0.53 0.14 0.82 0.85 0.75 0.93 5.92
Non-Cash Adjustments to Reconcile Net Income		 0.07 -1.21 -0.31 4.80 3.21 1.92 3.53 6.01 17 8.05 -5.20
Changes in Operating Assets and Liabilities, net		 -1.00 -0.12 0.78 -4.93 -1.98 1.86 -0.89 -0.94 -3.39 -0.81 -1.61
Net Cash From Investing Activities		 -141 -117 -148 -54 -153 -125 -104 -114 -114 -93 -48
Net Cash From Continuing Investing Activities		 -141 -117 -148 -54 -153 -125 -104 -113 -114 -92 -48
Purchase of Property, Leasehold Improvements and Equipment		 -130 -1.58 -1.13 -4.56 -4.37 -7.00 -7.22 -10 -19 -25 -21
Purchase of Investment Securities		 -11 -116 -147 -52 -150 -129 -102 -106 -101 -75 -65
Sale and/or Maturity of Investments		 0.00 0.10 0.83 0.09 1.20 10 3.98 3.00 6.19 7.42 37
Net Cash From Financing Activities		 140 102 126 29 120 78 48 63 45 34 -9.78
Net Cash From Continuing Financing Activities		 140 102 126 29 120 78 48 63 45 34 -9.78
Issuance of Debt		 17 34 60 49 75 18 125 150 50 162 46
Issuance of Common Equity		 129 87 109 10 107 98 38 21 44 7.49 0.00
Repayment of Debt		 -0.87 -0.63 -18 -0.33 -29 -0.11 -73 -63 -0.13 -83 0.00
Payment of Dividends		 -3.93 -18 -24 -29 -32 -38 -42 -44 -48 -52 -54
Other Financing Activities, Net		 0.00 -0.68 -0.39 - -0.45 -0.27 -0.22 -0.39 -1.19 -1.01 -2.11
Cash Interest Paid		 0.18 0.56 3.13 5.56 8.85 8.24 9.97 11 18 23 26

Quarterly Cash Flow Statements for Community Healthcare Trust

This table details how cash moves in and out of Community Healthcare Trust's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 1.26 -0.30 0.31 -4.21 2.10 1.55 -2.11 2.59 -1.48 -0.04 -0.72
Net Cash From Operating Activities		 18 14 13 17 14 16 14 14 13 16 14
Net Cash From Continuing Operating Activities		 18 14 13 17 14 16 14 14 13 16 14
Net Income / (Loss) Continuing Operations		 3.49 4.57 3.67 -10 1.75 1.83 1.59 -13 1.64 14 2.55
Consolidated Net Income / (Loss)		 3.49 4.57 3.67 -10 1.75 1.83 1.59 -13 1.64 14 2.55
Depreciation Expense		 11 10 10 11 11 11 11 11 11 11 11
Amortization Expense		 0.05 0.19 0.22 0.17 0.25 0.29 0.35 0.20 0.36 5.02 0.39
Non-Cash Adjustments to Reconcile Net Income		 1.78 1.16 1.67 2.81 1.81 1.87 2.07 5.30 2.44 -15 2.00
Changes in Operating Assets and Liabilities, net		 1.19 -1.87 -3.17 2.38 -0.90 0.87 -0.54 1.31 -2.62 0.25 -1.85
Net Cash From Investing Activities		 -55 -14 -39 -30 -14 -9.49 -13 -0.44 -31 -4.00 -27
Net Cash From Continuing Investing Activities		 -55 -14 -39 -30 -14 -9.43 -13 -0.44 -31 -4.00 -27
Purchase of Property, Leasehold Improvements and Equipment		 -3.58 -7.52 -5.11 -7.19 -7.19 -5.16 -4.68 -4.23 -5.08 -6.54 -4.97
Purchase of Investment Securities		 -52 -6.90 -34 -24 -8.91 -8.42 0.00 -9.71 -26 -29 -29
Sale and/or Maturity of Investments		 0.79 0.87 0.87 0.75 1.72 4.09 1.80 3.79 0.77 31 6.01
Other Investing Activities, net		 - - 0.03 0.05 0.08 0.06 -9.71 - - - 0.00
Net Cash From Financing Activities		 39 -1.04 26 9.32 2.64 -4.63 -3.93 -11 16 -12 13
Net Cash From Continuing Financing Activities		 39 -1.04 26 9.32 2.64 -4.63 -3.93 -11 16 -12 13
Issuance of Debt		 33 2.00 39 20 16 87 10 4.00 30 2.00 27
Payment of Dividends		 -12 -12 -13 -13 -13 -13 -13 -13 -13 -14 -14
Other Financing Activities, Net		 -0.04 -0.05 -0.61 -0.06 -0.29 -0.05 -0.67 -1.38 -0.06 - -0.33
Cash Interest Paid		 2.17 7.34 4.79 5.91 6.23 6.14 6.15 6.35 6.85 6.79 6.64
Cash Income Taxes Paid		 0.02 - 0.03 0.00 0.00 - 0.02 - - - 0.08

Annual Balance Sheets for Community Healthcare Trust

This table presents Community Healthcare Trust's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 143 252 386 427 563 668 754 876 945 993 991
Cash and Due from Banks		 2.02 1.57 2.13 2.01 1.73 2.48 2.35 11 3.49 4.38 3.34
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net		 128 234 352 390 525 632 701 778 849 903 923
Other Assets		 2.12 4.84 21 35 35 33 50 87 91 85 65
Total Liabilities & Shareholders' Equity		 143 252 386 427 563 668 754 876 945 993 991
Total Liabilities		 21 58 102 155 209 238 292 380 432 517 561
Other Short-Term Payables		 0.81 3.54 4.06 3.20 3.61 5.74 7.85 11 12 14 15
Long-Term Debt		 - 51 93 148 194 212 266 353 403 486 532
Other Long-Term Liabilities		 2.72 2.98 4.98 3.95 11 20 19 15 17 16 14
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 122 194 283 272 353 430 462 497 513 476 429
Total Preferred & Common Equity		 122 194 283 272 353 430 462 497 513 476 429
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 122 194 283 272 353 430 462 497 513 476 429
Common Stock		 128 214 324 337 448 551 596 625 688 705 718
Retained Earnings		 -5.38 -20 -41 -66 -90 -109 -129 -151 -192 -246 -295
Accumulated Other Comprehensive Income / (Loss)		 - 0.00 0.26 0.63 -4.81 -12 -4.98 23 16 18 6.69

Quarterly Balance Sheets for Community Healthcare Trust

This table presents Community Healthcare Trust's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 812 886 900 955 983 983 982 985 966 987 1,010
Cash and Due from Banks		 2.66 3.67 2.63 3.89 3.81 0.73 2.84 2.27 4.86 3.38 2.62
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net		 730 797 805 852 880 899 903 895 895 918 947
Other Assets		 79 85 92 98 98 84 76 88 66 66 60
Total Liabilities & Shareholders' Equity		 812 886 900 955 983 983 982 985 966 987 1,010
Total Liabilities		 333 392 395 433 471 485 505 524 528 560 589
Other Short-Term Payables		 8.14 10 11 15 12 12 14 12 14 17 16
Long-Term Debt		 311 365 368 401 442 458 474 496 500 530 559
Other Long-Term Liabilities		 15 16 16 16 17 16 16 16 14 13 13
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 478 495 505 522 512 498 477 461 438 427 421
Total Preferred & Common Equity		 478 495 505 522 512 498 477 461 438 427 421
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 478 495 505 522 512 498 477 461 438 427 421
Common Stock		 602 649 657 677 691 700 702 707 713 715 720
Retained Earnings		 -145 -170 -175 -184 -201 -224 -235 -258 -284 -296 -306
Accumulated Other Comprehensive Income / (Loss)		 21 16 23 29 21 21 10 12 9.12 7.57 7.40

Annual Metrics And Ratios for Community Healthcare Trust

This table displays calculated financial ratios and metrics derived from Community Healthcare Trust's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 7,596,940.00 12,988,482.00 18,085,798.00 18,533,802.00 20,177,693.00 23,429,998.00 24,982,506.00 - - - 28,471,424.00
DEI Adjusted Shares Outstanding		 7,596,940.00 12,988,482.00 18,085,798.00 18,533,802.00 20,177,693.00 23,429,998.00 24,982,506.00 - - - 28,471,424.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.19 0.21 0.19 0.24 0.42 0.81 0.90 - - - 0.18
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.00% 124.47% 91.97% 14.27% 21.81% 45.91% 5.60% 7.21% 11.64% -3.40% 14.49%
EBITDA Growth		 0.00% 172.23% 118.36% -9.57% 43.24% 64.64% 0.08% 2.99% 9.06% -32.75% 26.98%
EBIT Growth		 0.00% -71.52% 472.66% -63.31% 282.90% 186.46% -20.18% -1.61% -63.64% -139.66% 56.41%
NOPAT Growth		 0.00% -71.52% 716.31% -68.31% 227.06% 232.43% -19.47% -1.80% -64.97% -128.87% 122.44%
Net Income Growth		 0.00% 286.88% 29.00% 25.44% 90.23% 127.76% 17.90% -2.10% -64.97% -141.24% 260.39%
EPS Growth		 0.00% 177.42% -20.83% 0.00% 94.74% 116.22% 8.75% -6.90% -75.31% -215.00% 134.78%
Operating Cash Flow Growth		 0.00% 402.49% 48.21% 10.46% 32.41% 49.47% 16.49% 6.98% 1.83% -4.08% -4.16%
Free Cash Flow Firm Growth		 0.00% 0.00% -15.50% 67.54% -198.61% 44.27% 5.64% -58.75% 41.05% 19.25% 204.03%
Invested Capital Growth		 0.00% 75.92% 53.76% 11.33% 30.57% 17.28% 13.30% 16.77% 7.85% 4.95% -0.03%
Revenue Q/Q Growth		 0.00% -10.70% 59.71% -9.38% 5.16% 19.30% -7.32% 1.69% 2.41% -12.70% 0.00%
EBITDA Q/Q Growth		 0.00% -19.89% 99.86% -32.85% 39.35% 26.71% -11.53% -0.31% 1.86% -25.01% 82.40%
EBIT Q/Q Growth		 0.00% -186.23% 269.75% -81.47% 302.55% 57.52% -26.20% -2.99% -9.01% -113.96% 0.00%
NOPAT Q/Q Growth		 0.00% -160.36% 382.65% -74.06% 206.70% 58.93% -37.71% 9.37% 24.64% -605.32% 0.00%
Net Income Q/Q Growth		 0.00% 50.50% 17.35% -43.84% 95.79% 18.86% 4.04% -3.82% -8.00% -613.23% 0.00%
EPS Q/Q Growth		 0.00% -7.69% -17.39% -48.65% 146.67% 15.94% 3.57% -6.90% -4.76% -130.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 21.35% 13.51% -0.99% 8.94% 7.54% 4.50% 0.69% -1.79% 2.39% -0.29%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 16.05% 19.26% -12.11% -21.36% 33.14% -100.50% 53.93% -71.98% 630.00%
Invested Capital Q/Q Growth		 0.00% 20.84% 8.51% 3.11% 6.05% 9.05% 1.18% 7.67% -0.76% 1.16% 0.48%
Profitability Metrics		 - - - - - - - - - - -
EBITDA Margin		 48.78% 59.16% 67.30% 53.26% 62.63% 70.67% 66.98% 64.34% 62.86% 43.76% 61.31%
EBIT Margin		 -12.60% -9.63% 18.69% 6.00% 18.86% 37.03% 27.99% 25.69% 8.37% -3.43% 24.13%
Profit (Net Income) Margin		 -16.80% 13.99% 9.40% 10.32% 16.11% 25.15% 28.08% 25.64% 8.05% -3.43% 3.84%
Tax Burden Percent		 133.33% -147.64% 115.77% 154.17% 85.42% 68.32% 99.26% 99.81% 96.18% 100.00% 99.55%
Interest Burden Percent		 100.00% 98.40% 43.44% 111.52% 100.00% 99.41% 101.06% 100.00% 100.00% 100.00% 15.96%
Effective Tax Rate		 0.00% 0.00% -15.77% 0.00% 14.58% 0.29% 0.00% 0.19% 3.82% 0.00% 0.45%
Return on Invested Capital (ROIC)		 -0.55% -0.68% 2.60% 0.64% 1.73% 4.68% 3.27% 2.79% 0.87% -0.24% 3.32%
ROIC Less NNEP Spread (ROIC-NNEP)		 -4.62% 11.18% -3.73% 2.17% 1.73% 0.37% 3.30% 2.79% 0.87% -0.45% -1.95%
Return on Net Nonoperating Assets (RNNOA)		 -0.64% 2.40% -1.13% 0.94% 0.95% 0.19% 1.77% 1.80% 0.65% -0.41% -2.20%
Return on Equity (ROE)		 -1.19% 1.72% 1.47% 1.59% 2.68% 4.87% 5.04% 4.59% 1.53% -0.64% 1.13%
Cash Return on Invested Capital (CROIC)		 0.00% -55.71% -39.77% -10.08% -24.79% -11.23% -9.20% -12.68% -6.68% -5.07% 3.36%
Operating Return on Assets (OROA)		 -1.53% -0.95% 2.19% 0.63% 1.98% 4.56% 3.15% 2.71% 0.88% -0.33% 3.24%
Return on Assets (ROA)		 -2.04% 1.38% 1.10% 1.08% 1.69% 3.10% 3.16% 2.70% 0.85% -0.33% 0.51%
Return on Common Equity (ROCE)		 -1.19% 1.72% 1.47% 1.59% 2.68% 4.87% 5.04% 4.59% 1.53% -0.64% 1.13%
Return on Equity Simple (ROE_SIMPLE)		 -1.19% 1.40% 1.24% 1.62% 2.37% 4.44% 4.87% 4.43% 1.50% -0.67% 1.19%
Net Operating Profit after Tax (NOPAT)		 -0.76 -1.31 8.08 2.56 8.38 28 22 22 7.71 -2.23 32
NOPAT Margin		 -8.82% -6.74% 21.64% 6.00% 16.11% 36.71% 27.99% 25.64% 8.05% -2.40% 24.02%
Net Nonoperating Expense Percent (NNEP)		 4.07% -11.86% 6.33% -1.53% 0.00% 4.31% -0.03% 0.00% 0.00% 0.21% 5.28%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 112.60% 109.63% 81.31% 94.00% 81.14% 62.97% 72.01% 74.31% 91.63% 91.56% 69.35%
Earnings before Interest and Taxes (EBIT)		 -1.09 -1.87 6.98 2.56 9.81 28 22 22 8.02 -3.18 32
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 4.23 12 25 23 33 54 54 55 60 41 82
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.71 1.03 1.28 1.49 1.93 2.11 2.18 1.59 1.30 1.14 1.06
Price to Tangible Book Value (P/TBV)		 0.71 1.03 1.28 1.49 1.93 2.11 2.18 1.59 1.30 1.14 1.06
Price to Revenue (P/Rev)		 10.03 10.31 9.72 9.49 13.14 11.95 12.57 9.18 6.96 5.86 3.42
Price to Earnings (P/E)		 0.00 73.74 103.42 91.96 81.56 47.53 44.76 35.82 86.48 0.00 89.06
Dividend Yield		 4.52% 9.87% 7.80% 7.35% 4.86% 4.35% 4.28% 5.66% 7.38% 9.60% 11.81%
Earnings Yield		 0.00% 1.36% 0.97% 1.09% 1.23% 2.10% 2.23% 2.79% 1.16% 0.00% 1.12%
Enterprise Value to Invested Capital (EV/IC)		 0.73 1.02 1.21 1.31 1.60 1.74 1.74 1.33 1.16 1.06 1.02
Enterprise Value to Revenue (EV/Rev)		 11.76 12.85 12.16 12.89 16.84 14.72 15.85 13.15 11.12 11.06 7.39
Enterprise Value to EBITDA (EV/EBITDA)		 24.11 21.73 18.07 24.21 26.89 20.82 23.66 20.44 17.69 25.27 12.06
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 65.08 214.87 89.27 39.74 56.62 51.20 132.88 0.00 30.63
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 56.21 214.87 104.51 40.09 56.62 51.30 138.15 0.00 30.77
Enterprise Value to Operating Cash Flow (EV/OCF)		 34.31 16.75 20.53 22.51 27.05 23.08 22.53 18.74 17.36 17.39 17.42
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 30.45
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.14 0.26 0.33 0.54 0.55 0.49 0.57 0.71 0.79 1.02 1.24
Long-Term Debt to Equity		 0.00 0.26 0.33 0.54 0.55 0.49 0.57 0.71 0.79 1.02 1.24
Financial Leverage		 0.14 0.22 0.30 0.43 0.55 0.52 0.54 0.65 0.75 0.90 1.12
Leverage Ratio		 1.17 1.25 1.34 1.46 1.58 1.57 1.59 1.70 1.80 1.96 2.19
Compound Leverage Factor		 1.17 1.23 0.58 1.63 1.58 1.56 1.61 1.70 1.80 1.96 0.35
Debt to Total Capital		 12.21% 20.82% 24.78% 35.23% 35.47% 33.07% 36.50% 41.54% 44.00% 50.52% 55.35%
Short-Term Debt to Total Capital		 12.21% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 20.82% 24.78% 35.23% 35.47% 33.07% 36.50% 41.54% 44.00% 50.52% 55.35%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 87.79% 79.18% 75.22% 64.77% 64.53% 66.93% 63.50% 58.46% 56.00% 49.48% 44.65%
Debt to EBITDA		 4.02 4.43 3.71 6.50 5.97 3.96 4.95 6.39 6.69 11.99 6.53
Net Debt to EBITDA		 3.54 4.29 3.63 6.40 5.90 3.91 4.90 6.17 6.62 11.88 6.48
Long-Term Debt to EBITDA		 0.00 4.43 3.71 6.50 5.97 3.96 4.95 6.39 6.69 11.99 6.53
Debt to NOPAT		 -22.24 -38.90 11.55 57.70 23.19 7.63 11.85 16.03 52.28 -218.24 16.65
Net Debt to NOPAT		 -19.60 -37.70 11.29 56.76 22.95 7.52 11.72 15.48 51.68 -216.27 16.55
Long-Term Debt to NOPAT		 0.00 -38.90 11.55 57.70 23.19 7.63 11.85 16.03 52.28 -218.24 16.65
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -107 -124 -40 -120 -67 -63 -100 -59 -48 32
Operating Cash Flow to CapEx		 2.29% 945.47% 1,954.68% 1,769.80% 740.21% 716.91% 946.07% 580.96% 323.39% 238.93% 274.95%
Free Cash Flow to Firm to Interest Expense		 0.00 -90.87 0.00 -6.37 -12.89 0.00 -5.98 -8.43 -3.32 -2.01 0.00
Operating Cash Flow to Interest Expense		 0.00 12.67 0.00 3.88 3.48 0.00 5.35 5.08 3.45 2.48 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 11.33 0.00 3.66 3.01 0.00 4.78 4.20 2.38 1.44 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.12 0.10 0.12 0.11 0.11 0.12 0.11 0.11 0.11 0.10 0.13
Fixed Asset Turnover		 0.00 0.11 0.13 0.12 0.11 0.13 0.12 0.12 0.12 0.11 0.15
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 139 245 377 419 548 642 728 850 917 962 962
Invested Capital Turnover		 0.06 0.10 0.12 0.11 0.11 0.13 0.12 0.11 0.11 0.10 0.14
Increase / (Decrease) in Invested Capital		 0.00 106 132 43 128 95 85 122 67 45 -0.33
Enterprise Value (EV)		 102 250 454 550 875 1,116 1,269 1,130 1,066 1,024 983
Market Capitalization		 87 201 363 405 683 907 1,007 789 667 543 454
Book Value per Share		 $16.09 $14.94 $15.67 $14.66 $17.51 $18.35 $18.50 $19.64 $18.83 $16.85 $15.08
Tangible Book Value per Share		 $16.09 $14.94 $15.67 $14.66 $17.51 $18.35 $18.50 $19.64 $18.83 $16.85 $15.08
Total Capital		 139 245 377 419 548 642 728 850 917 962 962
Total Debt		 17 51 93 148 194 212 266 353 403 486 532
Total Long-Term Debt		 0.00 51 93 148 194 212 266 353 403 486 532
Net Debt		 15 49 91 145 192 209 263 341 399 482 529
Capital Expenditures (CapEx)		 130 1.58 1.13 1.38 4.37 6.75 5.96 10 19 25 21
Net Nonoperating Expense (NNE)		 0.69 -4.03 4.57 -1.84 0.00 8.77 -0.07 0.00 0.00 0.95 27
Net Nonoperating Obligations (NNO)		 17 51 93 148 194 212 266 353 403 486 532
Total Depreciation and Amortization (D&A)		 5.32 13 18 20 23 26 31 33 52 44 49
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.31) $0.24 $0.19 $0.19 $0.37 $0.80 $0.87 $0.81 $0.20 ($0.23) $0.08
Adjusted Weighted Average Basic Shares Outstanding		 4.73M 11.24M 14.82M 17.67M 18.68M 21.58M 23.26M 23.63M 25.20M 26.53M 26.86M
Adjusted Diluted Earnings per Share		 ($0.31) $0.24 $0.19 $0.19 $0.37 $0.80 $0.87 $0.81 $0.20 ($0.23) $0.08
Adjusted Weighted Average Diluted Shares Outstanding		 4.73M 11.32M 14.82M 17.67M 18.68M 21.58M 23.26M 23.63M 25.20M 26.53M 26.86M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 7.71M 13.11M 18.18M 18.72M 21.63M 24.01M 25.07M 26.02M 27.68M 28.34M 28.57M
Normalized Net Operating Profit after Tax (NOPAT)		 -0.76 -1.31 4.89 5.29 8.38 28 16 22 7.81 -2.14 32
Normalized NOPAT Margin		 -8.82% -6.74% 13.08% 12.40% 16.11% 36.71% 19.60% 25.64% 8.15% -2.31% 24.02%
Pre Tax Income Margin		 -12.60% -9.47% 8.12% 6.69% 18.86% 36.81% 28.29% 25.69% 8.37% -3.43% 3.85%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 -1.59 0.00 0.41 1.05 0.00 2.13 1.86 0.45 -0.13 0.00
NOPAT to Interest Expense		 0.00 -1.11 0.00 0.41 0.90 0.00 2.13 1.85 0.43 -0.09 0.00
EBIT Less CapEx to Interest Expense		 0.00 -2.93 0.00 0.19 0.58 0.00 1.56 0.98 -0.62 -1.17 0.00
NOPAT Less CapEx to Interest Expense		 0.00 -2.45 0.00 0.19 0.43 0.00 1.56 0.98 -0.63 -1.13 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 -269.78% 653.55% 696.07% 667.16% 381.41% 199.37% 188.54% 202.03% 623.01% -1,625.21% 1,051.92%
Augmented Payout Ratio		 -398.01% 653.55% 713.48% 670.72% 381.41% 199.37% 188.54% 202.03% 623.01% -1,625.21% 1,051.92%

Quarterly Metrics And Ratios for Community Healthcare Trust

This table displays calculated financial ratios and metrics derived from Community Healthcare Trust's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 - - - - - - 28,339,419.00 28,339,419.00 28,366,744.00 28,471,424.00 28,571,793.00
DEI Adjusted Shares Outstanding		 - - - - - - 28,339,419.00 28,339,419.00 28,366,744.00 28,471,424.00 28,571,793.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - 0.06 -0.44 0.06 0.51 0.09
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 10.61% 10.33% 4.58% 13.94% 23.85% -55.80% 0.00% 4.55% 1.19% 0.00% 32.67%
EBITDA Growth		 8.40% 7.96% -0.36% -59.49% 27.22% -95.40% -8.94% -31.09% 4.16% 241.63% 58.37%
EBIT Growth		 -33.00% -15.10% 153.22% -167.01% 109.62% -332.97% -56.59% -53.57% 8.91% 0.00% 487.49%
NOPAT Growth		 -36.65% 69.51% 176.02% -147.27% 122.51% -58.86% -56.59% -53.57% 8.91% 0.00% 487.49%
Net Income Growth		 -38.45% -12.81% 152.95% -258.54% -49.91% -59.89% 0.00% -20.43% -6.23% 0.00% 60.15%
EPS Growth		 -47.62% -5.56% 134.38% -275.00% -63.64% -76.47% 0.00% -19.05% -25.00% 0.00% 133.33%
Operating Cash Flow Growth		 15.41% -7.26% -0.43% 0.32% -21.85% 9.60% 0.00% 0.00% -8.11% -1.05% -4.64%
Free Cash Flow Firm Growth		 -102.95% 47.89% 26.61% 16.77% 85.16% 29.99% 98.04% 115.16% 113.53% 149.30% -681.97%
Invested Capital Growth		 17.01% 7.85% 10.98% 9.38% 2.97% 4.95% 0.35% -1.83% 0.64% -0.03% 2.43%
Revenue Q/Q Growth		 -1.32% 0.18% 0.54% 14.63% 7.27% -64.25% 0.00% -3.29% 3.83% 44.53% -27.89%
EBITDA Q/Q Growth		 -6.31% -1.14% -6.36% -53.92% 194.20% -96.42% 16.15% -76.74% 346.64% 89.61% -46.16%
EBIT Q/Q Growth		 -42.43% 17.04% -21.50% -221.17% 280.07% -230.07% 0.00% -183.16% 231.95% 153.01% -57.61%
NOPAT Q/Q Growth		 -45.36% 24.23% -21.50% -184.82% 357.25% -77.03% 0.00% -158.21% 288.49% 153.01% -57.61%
Net Income Q/Q Growth		 -46.91% 30.78% -19.75% -384.50% 116.77% 4.75% 0.00% -889.25% 113.06% 779.76% -82.34%
EPS Q/Q Growth		 -54.17% 54.55% -35.29% -481.82% 109.52% 0.00% 0.00% -1,766.67% 106.00% 1,633.33% -86.54%
Operating Cash Flow Q/Q Growth		 6.24% -19.33% -11.54% 32.32% -17.24% 13.14% -8.01% -4.23% -7.80% 21.84% -11.35%
Free Cash Flow Firm Q/Q Growth		 -27.83% 52.36% -46.26% 6.25% 77.21% -124.77% 96.08% 181.62% -79.64% 753.70% -162.18%
Invested Capital Q/Q Growth		 5.73% -0.76% 4.09% 0.15% -0.47% 1.16% -0.48% -2.03% 2.03% 0.48% 1.98%
Profitability Metrics		 - - - - - - - - - - -
EBITDA Margin		 62.55% 61.72% 58.27% 23.43% 64.25% 6.43% 54.28% 15.38% 66.14% 86.77% 64.79%
EBIT Margin		 15.83% 18.50% 15.10% -15.96% 26.80% -97.49% 6.70% -22.71% 28.85% 50.51% 29.69%
Profit (Net Income) Margin		 14.49% 18.92% 15.10% -37.48% 5.86% 17.17% 6.70% -43.17% 5.43% 33.05% 8.09%
Tax Burden Percent		 91.53% 102.28% 100.00% 100.00% 100.29% 99.73% 100.00% 100.00% 100.00% 99.86% 100.00%
Interest Burden Percent		 100.00% 100.00% 100.00% 234.79% 21.81% -17.66% 100.00% 190.11% 18.82% 65.52% 27.26%
Effective Tax Rate		 5.79% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 1.63% 2.01% 1.61% -1.23% 3.03% 1.70% 0.00% 0.00% 0.00% 6.99% 4.31%
ROIC Less NNEP Spread (ROIC-NNEP)		 1.60% 2.03% 1.61% -3.00% 1.60% 1.70% 0.00% 0.00% 0.00% 5.49% 3.03%
Return on Net Nonoperating Assets (RNNOA)		 1.14% 1.52% 1.30% -2.47% 1.40% 1.53% 0.00% 0.00% 0.00% 6.17% 3.62%
Return on Equity (ROE)		 2.77% 3.53% 2.91% -3.69% 4.44% 3.22% 0.00% 0.00% 0.00% 13.16% 7.93%
Cash Return on Invested Capital (CROIC)		 -14.95% -6.68% -8.38% -8.78% -2.96% -5.07% -0.35% 1.85% -0.64% 3.36% 1.71%
Operating Return on Assets (OROA)		 1.68% 1.95% 1.57% -1.70% 2.94% -9.32% 0.00% 0.00% 0.00% 6.78% 4.19%
Return on Assets (ROA)		 1.54% 1.99% 1.57% -3.99% 0.64% 1.64% 0.00% 0.00% 0.00% 4.43% 1.14%
Return on Common Equity (ROCE)		 2.77% 3.53% 2.91% -3.69% 4.44% 3.22% 0.00% 0.00% 0.00% 13.16% 7.93%
Return on Equity Simple (ROE_SIMPLE)		 1.61% 0.00% 3.58% 0.26% -0.09% 0.00% 0.00% 0.00% 0.00% 0.00% 1.44%
Net Operating Profit after Tax (NOPAT)		 3.59 4.47 3.67 -3.11 8.00 1.84 1.59 -4.62 8.72 22 9.35
NOPAT Margin		 14.91% 18.50% 15.10% -11.17% 26.80% 17.22% 6.70% -15.89% 28.85% 50.51% 29.69%
Net Nonoperating Expense Percent (NNEP)		 0.03% -0.03% 0.00% 1.77% 1.43% 0.00% 0.00% 1.66% 1.41% 1.50% 1.29%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 84.17% 81.50% 84.90% 76.43% 73.20% 197.49% 93.30% 92.89% 71.15% 49.49% 70.31%
Earnings before Interest and Taxes (EBIT)		 3.82 4.47 3.67 -4.44 8.00 -10 1.59 -6.61 8.72 22 9.35
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 15 15 14 6.52 19 0.69 13 4.47 20 38 20
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.40 1.30 1.35 1.27 1.07 1.14 0.99 1.08 1.02 1.06 1.08
Price to Tangible Book Value (P/TBV)		 1.40 1.30 1.35 1.27 1.07 1.14 0.99 1.08 1.02 1.06 1.08
Price to Revenue (P/Rev)		 7.80 6.96 7.15 6.30 4.80 5.86 0.00 0.00 0.00 3.42 3.22
Price to Earnings (P/E)		 87.07 86.48 37.65 451.84 0.00 0.00 0.00 0.00 0.00 89.06 74.93
Dividend Yield		 6.53% 7.38% 7.14% 8.00% 10.11% 9.60% 11.52% 11.21% 12.25% 11.81% 11.93%
Earnings Yield		 1.15% 1.16% 2.66% 0.22% 0.00% 0.00% 0.00% 0.00% 0.00% 1.12% 1.33%
Enterprise Value to Invested Capital (EV/IC)		 1.22 1.16 1.18 1.14 1.03 1.06 0.99 1.03 1.00 1.02 1.03
Enterprise Value to Revenue (EV/Rev)		 12.03 11.12 11.66 10.85 9.24 11.06 0.00 0.00 0.00 7.39 7.18
Enterprise Value to EBITDA (EV/EBITDA)		 19.04 17.69 23.30 21.81 18.14 25.27 0.00 21.65 21.49 12.06 10.34
Enterprise Value to EBIT (EV/EBIT)		 127.79 132.88 60.53 58.53 43.01 0.00 0.00 0.00 0.00 30.63 20.82
Enterprise Value to NOPAT (EV/NOPAT)		 182.00 138.15 61.42 672.23 0.00 0.00 0.00 0.00 0.00 30.77 25.36
Enterprise Value to Operating Cash Flow (EV/OCF)		 18.02 17.36 18.43 17.74 17.04 17.39 0.00 16.75 16.98 17.42 18.12
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 55.23 0.00 30.45 60.91
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.77 0.79 0.86 0.92 0.99 1.02 1.08 1.14 1.24 1.24 1.33
Long-Term Debt to Equity		 0.77 0.79 0.86 0.92 0.99 1.02 1.08 1.14 1.24 1.24 1.33
Financial Leverage		 0.71 0.75 0.80 0.82 0.88 0.90 0.96 1.02 1.11 1.12 1.20
Leverage Ratio		 1.77 1.80 1.86 1.88 1.94 1.96 2.02 2.08 2.18 2.19 2.26
Compound Leverage Factor		 1.77 1.80 1.86 4.41 0.42 -0.35 2.02 3.96 0.41 1.44 0.62
Debt to Total Capital		 43.44% 44.00% 46.37% 47.90% 49.82% 50.52% 51.81% 53.32% 55.40% 55.35% 57.03%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 43.44% 44.00% 46.37% 47.90% 49.82% 50.52% 51.81% 53.32% 55.40% 55.35% 57.03%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 56.56% 56.00% 53.63% 52.10% 50.18% 49.48% 48.19% 46.68% 44.60% 44.65% 42.97%
Debt to EBITDA		 6.78 6.69 9.12 9.16 8.77 11.99 0.00 11.20 11.86 6.53 5.72
Net Debt to EBITDA		 6.70 6.62 9.02 9.15 8.71 11.88 0.00 11.10 11.78 6.48 5.69
Long-Term Debt to EBITDA		 6.78 6.69 9.12 9.16 8.77 11.99 0.00 11.20 11.86 6.53 5.72
Debt to NOPAT		 64.82 52.28 24.04 282.48 -1,500.53 -218.24 0.00 0.00 0.00 16.65 14.03
Net Debt to NOPAT		 64.03 51.68 23.77 282.03 -1,491.54 -216.27 0.00 0.00 0.00 16.55 13.97
Long-Term Debt to NOPAT		 64.82 52.28 24.04 282.48 -1,500.53 -218.24 0.00 0.00 0.00 16.65 14.03
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -131 -62 -91 -85 -19 -44 -1.78 13 2.62 22 -14
Operating Cash Flow to CapEx		 495.30% 190.05% 247.27% 232.83% 192.69% 303.51% 307.75% 326.29% 250.63% 237.11% 276.63%
Free Cash Flow to Firm to Interest Expense		 -28.15 -12.40 -17.92 0.00 0.00 -2.34 -0.28 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 3.82 2.85 2.50 0.00 0.00 0.84 2.27 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 3.05 1.35 1.49 0.00 0.00 0.56 1.53 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.11 0.11 0.10 0.11 0.11 0.10 0.00 0.00 0.00 0.13 0.14
Fixed Asset Turnover		 0.12 0.12 0.12 0.12 0.12 0.11 0.00 0.00 0.00 0.15 0.15
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 923 917 954 955 951 962 957 938 957 962 981
Invested Capital Turnover		 0.11 0.11 0.11 0.11 0.11 0.10 0.00 0.00 0.00 0.14 0.15
Increase / (Decrease) in Invested Capital		 134 67 94 82 27 45 3.37 -17 6.09 -0.33 23
Enterprise Value (EV)		 1,126 1,066 1,130 1,089 980 1,024 950 966 961 983 1,011
Market Capitalization		 730 667 693 632 509 543 456 471 434 454 454
Book Value per Share		 $19.67 $18.83 $19.46 $17.97 $17.01 $16.85 $16.28 $16.33 $15.05 $15.08 $14.75
Tangible Book Value per Share		 $19.67 $18.83 $19.46 $17.97 $17.01 $16.85 $16.28 $16.33 $15.05 $15.08 $14.75
Total Capital		 923 917 954 955 951 962 957 938 957 962 981
Total Debt		 401 403 442 458 474 486 496 500 530 532 559
Total Long-Term Debt		 401 403 442 458 474 486 496 500 530 532 559
Net Debt		 396 399 437 457 471 482 494 495 527 529 557
Capital Expenditures (CapEx)		 3.58 7.52 5.11 7.19 7.19 5.16 4.68 4.23 5.08 6.54 4.97
Net Nonoperating Expense (NNE)		 0.10 -0.10 0.00 7.32 6.25 0.01 0.00 7.93 7.08 7.62 6.80
Net Nonoperating Obligations (NNO)		 401 403 442 458 474 486 496 500 530 532 559
Total Depreciation and Amortization (D&A)		 11 10 10 11 11 11 11 11 11 16 11
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.11 $0.17 $0.11 ($0.42) $0.04 $0.04 $0.03 ($0.50) $0.03 $0.52 $0.07
Adjusted Weighted Average Basic Shares Outstanding		 25.51M 25.20M 26.30M 26.48M 26.66M 26.53M 26.73M 26.80M 26.93M 26.86M 26.99M
Adjusted Diluted Earnings per Share		 $0.11 $0.17 $0.11 ($0.42) $0.04 $0.04 $0.03 ($0.50) $0.03 $0.52 $0.07
Adjusted Weighted Average Diluted Shares Outstanding		 25.51M 25.20M 26.30M 26.48M 26.66M 26.53M 26.73M 26.80M 26.93M 26.86M 26.99M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 27.26M 27.68M 27.70M 28.06M 28.24M 28.34M 28.34M 28.37M 28.47M 28.57M 28.57M
Normalized Net Operating Profit after Tax (NOPAT)		 3.59 3.13 2.57 -3.01 5.60 1.29 1.11 -4.62 6.10 15 6.54
Normalized NOPAT Margin		 14.91% 12.95% 10.57% -10.82% 18.76% 12.05% 4.69% -15.89% 20.20% 35.36% 20.78%
Pre Tax Income Margin		 15.83% 18.50% 15.10% -37.48% 5.84% 17.22% 6.70% -43.17% 5.43% 33.10% 8.09%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.82 0.89 0.72 0.00 0.00 -0.56 0.25 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.77 0.89 0.72 0.00 0.00 0.10 0.25 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.05 -0.61 -0.29 0.00 0.00 -0.83 -0.49 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 -0.61 -0.29 0.00 0.00 -0.18 -0.49 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 559.51% 623.01% 268.28% 3,858.67% -11,430.72% -1,625.21% 0.00% 0.00% 0.00% 1,051.92% 892.49%
Augmented Payout Ratio		 559.51% 623.01% 268.28% 3,858.67% -11,430.72% -1,625.21% 0.00% 0.00% 0.00% 1,051.92% 892.49%

Financials Breakdown Chart

Key Financial Trends

Community Healthcare Trust (NYSE: CHCT) showed a meaningful rebound in profitability in Q1 2026, but the longer-term picture remains mixed. The quarter delivered solid operating cash flow and a return to positive earnings, yet leverage remains elevated and revenue is still heavily dependent on non-interest income and asset activity rather than recurring core interest income.

On the income statement, CHCT reported $31.5 million in revenue in Q1 2026 versus $30.2 million in Q3 2025 and $43.7 million in Q4 2025. More importantly, the company swung to $2.5 million in net income in Q1 2026, compared with a $12.6 million loss in Q2 2025 and $1.6 million of profit in Q3 2025. That suggests earnings are recovering, but results are still choppy from quarter to quarter.

Cash flow was a bright spot. CHCT generated $13.7 million of operating cash flow in Q1 2026, down from $15.5 million in Q4 2025 but still healthy. The company also continued to fund dividends, paying $13.7 million in Q1 2026, which shows shareholder returns remain a priority. However, cash balances were still low at just $2.6 million at quarter-end.

The balance sheet shows a company that is still carrying substantial debt. Long-term debt increased to $559.3 million in Q1 2026 from $530.1 million in Q3 2025 and $496.0 million in Q1 2025. At the same time, total equity fell to $421.3 million from $426.8 million in the prior quarter and $461.3 million a year earlier. That means leverage remains a key issue investors should watch closely.

  • Q1 2026 net income turned positive at $2.5 million after the prior year included volatile swings, signaling a rebound in profitability.
  • Operating cash flow remained strong at $13.7 million, supporting dividends and ongoing capital spending.
  • Depreciation and amortization continue to provide meaningful non-cash support to cash generation, helping fund operations.
  • Total assets increased to $1.01 billion from $987.3 million in Q3 2025, reflecting continued balance sheet growth.
  • Revenue remains uneven quarter to quarter, with results heavily influenced by non-interest income and noncore items.
  • EPS improved to $0.07 in Q1 2026 from $0.03 in Q3 2025, but earnings power is still modest.
  • Dividend payments remain large at $13.7 million in the quarter, indicating a continued income-focused capital policy.
  • Long-term debt rose further to $559.3 million, increasing financial leverage.
  • Cash declined to just $2.6 million, leaving a very thin liquidity cushion.
  • Retained earnings remain deeply negative at -$306.2 million, highlighting a long history of cumulative losses.

Looking at the multi-year trend, CHCT has made progress from the weaker periods in 2023 and early 2024, when it posted losses and higher volatility in operating results. The company has since stabilized earnings and maintained solid operating cash flow, but the stock still looks like a levered, dividend-supported recovery story rather than a clean, consistently growing earnings compounder.

Bottom line: CHCT’s latest quarter was encouraging, but investors should balance the improving earnings trend against high debt, low cash, and inconsistent revenue quality.

07/09/26 01:37 AM ETAI Generated. May Contain Errors.

Community Healthcare Trust Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Community Healthcare Trust's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Community Healthcare Trust's net income appears to be on an upward trend, with a most recent value of $5.10 million in 2025, falling from -$1.46 million in 2015. The previous period was -$3.18 million in 2024. See Community Healthcare Trust's forecast for analyst expectations on what's next for the company.

Over the last 10 years, Community Healthcare Trust's total revenue changed from $8.67 million in 2015 to $133.03 million in 2025, a change of 1,434.9%.

Community Healthcare Trust's total liabilities were at $561.37 million at the end of 2025, a 8.7% increase from 2024, and a 2,634.0% increase since 2015.

In the past 10 years, Community Healthcare Trust's cash and equivalents has ranged from $1.57 million in 2016 to $11.23 million in 2022, and is currently $3.34 million as of their latest financial filing in 2025.

Over the last 10 years, Community Healthcare Trust's book value per share changed from 16.09 in 2015 to 15.08 in 2025, a change of -6.3%.


Related Companies

Financial statements for NYSE:CHCT last updated on 7/2/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Better than SpaceX? Grab this ticker instead.
Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...
Brownstone Research | Sponsoredtc pixel